About Us
A winning portfolio
Intervet places great value on collaboration and innovation. We combine continuous discussion and exchange of views with veterinarians, farmers and other animal healthcare professionals, with careful monitoring of events and trends affecting every aspect of the markets we serve. By doing this, we are able to keep our product portfolio absolutely current as we broaden its range. This, in turn, means we can offer all those involved in animal healthcare effective tools to meet their changing needs.
Vaccines
Our position as a leader in the field of vaccines is due to our expertise in applying new technologies and developing novel products. Our readiness to draw inspiration from scientific advances has enabled us to assemble a portfolio containing a host of unique products, including many ‘firsts’ in terms of technological applications and disease coverage.
Marker technology
Marker vaccines help veterinarians and farmers to differentiate vaccinated animals from those exposed to field infections. For pigs, Intervet’s Porcilis® AD Begonia is the world’s best-selling Aujeszky’s Disease vaccine.
Our range also includes marker vaccines for other major livestock diseases including foot and mouth disease, classical swine fever and infectious bovine rhinotracheitis. We also play an active role in holding at bay the threat of an avian influenza epidemic, with heterologous vaccination allowing differentiation of vaccinated and infected poultry.
By enabling tests to differentiate vaccinated from naturally-infected animals, Intervet has helped both veterinarians and farmers avoid the slaughter-only policies previously widely favoured. These tests play a vital role in helping to prevent a repeat of government enforced mass culling events like the foot and mouth disease outbreak that hit the UK in 2001.
Live and inactivated vaccines
In swine, the respiratory vaccine range is complete, with Porcilis® PRRS as the leading product. Another important biological is Porcilis® APP, the only sub-unit vaccine available in the market against the severe respiratory disease induced by A.pleuropneumoniae. Porcilis® AD Begonia was the first centrally approved marker vaccine in Europe to eradicate Aujeszky’s disease in pigs, with over 500 million doses sold. The Intervet vaccine range also extensively covers cattle and sheep. Bovilis® Bovipast RSP is an inactivated vaccine against respiratory disease in cattle. Decivac FMD DOE is an inactivated oil adjuvant vaccine against foot and mouth disease for the active immunization of cattle, buffalo and sheep.
Infectious diseases can have a dramatic effect on flock performance and profitability in the poultry industry. Intervet’s Nobilis® range of live and inactivated vaccines protects poultry against a wide range of viral and bacterial diseases. Nobilis® Gumboro 228 E and Gumboro D78 are our live vaccines against infectious bursal disease (Gumboro) in chickens. Salenvac T, the combined vaccine to Salmonella enteritidis and Salmonella typhimurium, protects poultry against the most common types of Salmonella that cause food poisoning in humans.
Companion animal vaccines
Equilis® Prequenza is the first commercially available equine influenza vaccine with proven protection against the most recent influenza strains in horses. The Nobivac® and Continuum® vaccines provide protection for millions of dogs and cats around the world. The vaccines meet the highest standard of efficacy and safety. Nobivac® Parvo-C was the world’s first vaccine capable of immunizing puppies against parvovirus infections in the face of maternal immunity. Nobivac® KC, an intranasal canine kennel cough vaccine provides a proven full year of immunity against both major causes of kennel cough with a single vaccination.
Pharmaceuticals
Intervet’s pharmaceutical range is equally comprehensive. This spans antiparasitics, anti-infectives, fertility treatments and reproductive aids, as well as a growing range of speciality products.
Antiparasitics and anti-infectives
Scalibor ProtectorBand is the only product available for dogs that prevents sand fly bites thereby protecting dogs against leishmaniasis, a deadly parasitic disease. Panacur (fenbendazole) is a broad-spectrum anthelmintic, with an outstanding safety profile, for use in all major livestock and companion animal species. Our proprietary antibiotic Cobactan (cefquinome) spearheads our growing anti-infectives portfolio.
Speciality products
Products such as Regumate (altrenogest), the first oral progestagen for fertility management in pigs and horses, and PG600, the first swine fertility treatment with a track record of more than 30 years, enjoy outstanding reputations in the animal healthcare profession.
Our canine ACE inhibitor, Vasotop® (ramipril), to treat heart failure in dogs, and Caninsulin® (also known as Vetsulin®), the first and only insulin product developed specifically for the safe and effective management of diabetes mellitus in dogs and cats, have both been successful additions to our portfolio.